Hepatology
You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
AASLD Publications
Hepatology
Liver Transplantation
Hepatology Communications
Clinical Liver Disease
AASLD Publications
Hepatology
Liver Transplantation
Hepatology Communications
Clinical Liver Disease
Log in
or
Register
Subscribe to journal
Subscribe
Get new issue alerts
Get alerts
AASLD Member? Login here
Enter your Email address:
Privacy Policy
Subscribe to eTOC
Secondary Logo
Journal Logo
All
Articles
Images
Videos
Podcasts
Blogs
Advanced Search
Toggle navigation
Subscribe
Register
Login
Home
Currently selected
Browse
Articles in Press
Current Issue
All Issues
Collections
Video Gallery
Review Articles
Graphical Abstracts
Top Cited Articles
Top Altmetric Articles
Multi-journal Article Collections
The Future of Hepatology
2024 Impact Factor: Top Cited Articles
About
About the Journal
About AASLD
Editorial Board
Instructions for Authors
Advertising
Permissions
Open Access
Reprints
For Authors
Instructions for Authors
Submit an Article
Language Editing Services
Graphical Abstract Guidelines
Author Promotion Toolkit
Resources
Publish with Us
AASLD Career Center
Joint GI Society Statement on Racism
What is Hepatology looking for 2.0?
COVID-19 Resources
LiverLearning
AASLD SIGnal
Become a Member
AASLD Guidelines
Submit an Article
All
Articles
Images
Videos
Podcasts
Blogs
Advanced Search
Optimizing bevacizumab exposure in atezolizumab-based therapy for unresectable hepatocellular carcinoma: A nationwide real-world study
CD4+ T cells promote fibrosis during metabolic dysfunction–associated steatohepatitis
Neoadjuvant and adjuvant nivolumab associated with irreversible electroporation in patients with early hepatocellular carcinoma and high risk of recurrence (NIVOLEP trial)
A randomized, open-label, phase 2a study to assess the safety, pharmacodynamics, and pharmacokinetics of YAQ007 versus rifaximin in cirrhosis
Latest Articles
Graphical Abstracts
Reviews
AASLD Guidelines
Latest Articles
H4K12 lactylation drives
TREM2
high
macrophages differentiation in liver fibrosis
Macrophage–neutrophil crosstalk via the Selplg–Sell–YAP axis drives NETosis and MASH-associated liver fibrosis
Vitamin E dosing study (VEDS) in patients with metabolic dysfunction-associated steatotic liver disease with elevated aminotransferases: A multicenter, randomized, placebo-controlled trial
High resolution spatial transcriptomics identifies insufficient radiofrequency ablation induces hepatocellular carcinoma progression via CEBPD / CXCL2 axis
HBsAg seroclearance further reduces hepatocellular carcinoma but not hepatic decompensation in patients with cirrhosis and complete viral suppression
View More Recent Articles
✕
